Skip to main content
Clinical Trials/NCT03532919
NCT03532919
Completed
Not Applicable

Heart and Renal Failure in Hip Fracture Surgery

Sahlgrenska University Hospital, Sweden1 site in 1 country105 target enrollmentFebruary 1, 2018

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Hypotension
Sponsor
Sahlgrenska University Hospital, Sweden
Enrollment
105
Locations
1
Primary Endpoint
Mortality
Status
Completed
Last Updated
7 years ago

Overview

Brief Summary

Patients with acute hip fractures are old and vulnerable. With a majoriry classified as being ASA 3 or more. Frequently they receive spinal anesthesia perioperatively inducing hypotension. Even a short hypotensive period may induce postop cardiac T roponinT leakage as well as renal failure noted by Changes in Serum Creatinin or Cýstatin C This will be investigated and correlated to intraoperative hypotension as step one. Preliminary this will be followed by an intervention with vasopressor treatment perioperatively to preserve an adequte MABP

Detailed Description

Patients with acute hip fractures are old and vulnerable. With a majoriry classified as being ASA 3 or more. Frequently they receive spinal anesthesia perioperatively inducing hypotension. Even a short hypotensive period may induce postop cardiac T roponinT leakage as awell as renal failure noted by Changes in S Creatinin or Cýstatin C This will be investigated and correlated to intraoperative hypotension as a step one. Preliminary this will be followed by an intervention with vasopressor treatment perioperatively to preserve an adequte MABP

Registry
clinicaltrials.gov
Start Date
February 1, 2018
End Date
December 1, 2018
Last Updated
7 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
Sahlgrenska University Hospital, Sweden
Responsible Party
Principal Investigator
Principal Investigator

Bengt Nellgard

Associate professor

Sahlgrenska University Hospital, Sweden

Eligibility Criteria

Inclusion Criteria

  • Hip fracture patient to be operated upon Classified as being ASA 3 or more

Exclusion Criteria

  • Not forfilling inclusion Criterias

Outcomes

Primary Outcomes

Mortality

Time Frame: 90 days

post surgery

Secondary Outcomes

  • Serum concentrations of Troponin, NTproBNP, Creatinin and Cystatin C(90 days)

Study Sites (1)

Loading locations...

Similar Trials